Harte Hanks Reports Second Quarter 2017 Results SAN

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
46
Harte Hanks Reports Second Quarter 2017 Results

SAN ANTONIO, Texas, Sept. 28, 2017 (GLOBE NEWSWIRE) -- Harte Hanks (NYSE: HHS ), a leader in developing customer relationships, experiences and defining interaction-led marketing, today announced financial results for its second quarter 2017, ended June 30, 2017.

Commenting on performance, President and Chief Executive Officer Karen Puckett said, “Consistent with our expectations we continue to see improved trends, driven by our focus on customer satisfaction and client retention.  We continue to attract new clients with revamped marketing, sales and new service innovation, which was the foundation for achieving our new sales bookings plan for the quarter, doubling our first quarter bookings.  During the second quarter, our rate of revenue decline improved to 2.7% year-over-year which is much better than the second quarter of 2016.  In addition, our efforts to streamline the business and more effectively manage our costs structure resulted in an operating loss improvement of $4.9 million from the year ago period.”

Ms. Puckett continued, “Our strategy remains the same: improve our financial results by focusing on customer satisfaction and client retention while attracting new clients with revamped marketing, sales and innovative capabilities.” 

Second Quarter Results

Second quarter 2017 revenues were $94.7 million compared to $97.3 million during the same quarter last year, representing a 2.7% decline from the same period last year.  Second quarter 2017 operating loss from continuing operations was $1.8 million, a $4.9 million improvement compared to an operating loss from continuing operations of $6.7 million in the year-ago quarter.

Net loss from continuing operations for the second quarter of 2017 was $2.7 million or $0.04 per share, an improvement of $4.3 million, or $0.07 per share, compared the year-ago quarter.

Chief Financial Officer, Robert Munden said, “During the quarter our cash flows included payment of $34 million in taxes related to the Trillium sale, $1.3 million for capital expenditures, and $2 million for a lawsuit loss accrued in 2016.  We continue to believe that our net cash position will improve in the second half of 2017, and that we have the financial flexibility to effectively run the business.”

The following table presents financial highlights of the company's operations for the second quarter of 2017 and 2016, respectively. More detailed financial results are attached.

RESULTS FROM OPERATIONS
(In thousands, except per share amounts) Three Months Ended June 30,
    2017     2016    % Change*
Revenues from continuing operations $   94,722   $ 97,317   (2.7 )
Operating loss from continuing operations   (1,791 )     (6,689 ) 73.2  
Net loss from continuing operations   (2,653 )     (6,912 ) 61.6  
Loss per share   (0.04 )   (0.11 ) 63.6  
Shares outstanding (weighted average common and common equivalent shares outstanding)   61,896     61,460   0.7  

* Improvements shown as positive.

The company will host a conference call to discuss the earnings release today at 10:00 a.m. Eastern Time. To access an audio webcast, please use the link available in the Investors Events section of the Harte Hanks website.

The telephonic conference call number is (877) 329-7568 for domestic callers and +1 (719) 457-2641 for international callers. The conference ID is 7067975.

An audio replay will be available shortly after the call through Saturday, October 28, 2017 at (844) 512-2921, or +1 (412) 317-6671, with conference ID 7067975. The replay also will be available for one year in the Investors section of the Harte Hanks website.

                                                       
  Harte Hanks, Inc.                                            
  Consolidated Statements of Operations (Unaudited)                          
          Three Months Ended June 30,   Six Months Ended June 30,  
  In thousands, except per share data                      2017       2016       2017       2016    
  Operating revenues                           $   94,722     $   97,317     $   189,616     $   196,880    
  Operating expenses                                                            
    Labor                                       57,103         62,444         117,453         124,996    
    Production and distribution                           26,521         27,427         53,399         57,306    
    Advertising, selling, general and administrative                             10,226         10,934         21,286         23,577    
    Depreciation, software and intangible asset amortization                   2,663         3,201         5,610         6,237    
      Total operating expenses                           96,513         104,006         197,748         212,116    
  Operating loss                                     (1,791 )       (6,689 )       (8,132 )       (15,236 )  
  Other expenses                                                             
    Interest expense, net                               1,235         2,400         2,258         3,781    
    Other, net                                   1,826         597         3,324         348    
      Total other expenses                                     3,061         2,997         5,582         4,129    
  Loss from continuing operations before income taxes                 (4,852 )       (9,686 )       (13,714 )       (19,365 )  
  Income tax benefit                                   (2,199 )       (2,774 )       (3,675 )       (5,506 )  
  Loss from continuing operations                           (2,653 )       (6,912 )       (10,039 )       (13,859 )  
                                                                       
  Income from discontinued operations, net of income taxes               -          2,649         -          3,993    
                                                                       
  Net loss                                   $   (2,653 )   $   (4,263 )   $   (10,039 )   $   (9,866 )  
                                                                       
  Basic earnings (loss) per common share                                                
  Continuing operations                           $   (0.04 )   $   (0.11 )   $   (0.16 )   $   (0.23 )  
  Discontinued operations                               -          0.04         -          0.07    
  Basic loss per common share                       $   (0.04 )   $   (0.07 )   $   (0.16 )   $   (0.16 )  
                                                                       
  Weighted-average common shares outstanding                     61,896         61,460         61,792         61,395    
                                                                       
  Diluted earnings (loss) per common share                                                
  Continuing operations                           $   (0.04 )   $   (0.11 )   $   (0.16 )   $   (0.23 )  
  Discontinued operations                               -          0.04         -          0.07    
  Diluted loss per common share                       $   (0.04 )   $   (0.07 )   $   (0.16 )   $   (0.16 )  
                                                                       
  Weighted-average common and common equivalent shares outstanding     61,896         61,460         61,792         61,395    
                                                       
                                                       
  Balance Sheet Data (Unaudited)                     June 30,   December 31,          
  In thousands                                 2017       2016            
                                                       
  Cash and cash equivalents                         $   13,074     $   46,005            
  Total debt                                   $   12,116     $   -             
                                                       

 

                                 
  Harte Hanks, Inc.                      
  Revenue Mix (Unaudited)                  
                                 
  Vertical Markets - Percent of Revenue          
                      Three Months Ended June 30,   Six Months Ended June 30,  
                      2017   2016     2017   2016    
  Auto and Consumer Brands                   25.2 % 22.3 %   23.7 % 22.1 %  
  Financial and Insurance Services     15.5 % 14.6 %   15.7 % 14.2 %  
  Healthcare and Pharmaceuticals     5.4 % 7.6 %   5.8 % 8.2 %  
  B2B                 21.6 % 21.6 %   22.2 % 21.3 %  
  Retail                   24.1 % 25.6 %   24.2 % 25.9 %  
  Transportation             8.2 % 8.3 %   8.4 % 8.3 %  
                      100.0 % 100.0 %   100.0 % 100.0 %  
                                 

 

About Harte Hanks: Harte Hanks is a global marketing services firm specializing in multi-channel marketing solutions that connect our clients with their customers in powerful ways.  Experts in defining, executing and optimizing the customer journey, Harte Hanks offers end-to-end marketing services including consulting, strategic assessment, data, analytics, digital, social, mobile, print, direct mail and contact center.  From visionary thinking to tactical execution, Harte Hanks delivers smarter customer interactions for some of the world's leading brands. Harte Hanks 5,000+ employees are located in North America, Asia-Pacific and Europe.  For more information, visit Harte Hanks at www.hartehanks.com, call 800-456-9748, email us at pr@hartehanks.com.  Follow us on Twitter @hartehanks or Facebook at https://www.facebook.com/HarteHanks . 

Cautionary Note Regarding Forward-Looking Statements:

Our press release and related earnings conference call contain “forward-looking statements” within the meaning of U.S. federal securities laws.  All such statements are qualified by this cautionary note, provided pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.  Statements other than historical facts are forward-looking and may be identified by words such as “may,” “will,” “expects,” “believes,” “anticipates,” “plans,” “estimates,” “seeks,” “could,” “intends,” or words of similar meaning.  These forward-looking statements are based on current information, expectations and estimates and involve risks, uncertainties, assumptions and other factors that are difficult to predict and that could cause actual results to vary materially from what is expressed in or indicated by the forward-looking statements.  In that event, our business, financial condition, results of operations or liquidity could be materially adversely affected and investors in our securities could lose part or all of their investments.  These risks, uncertainties, assumptions and other factors include: (a) local, national and international economic and business conditions, including (i) market conditions that may adversely impact marketing expenditures and (ii) the impact of economic environments and competitive pressures on the financial condition, marketing expenditures and activities of our clients and prospects; (b) the demand for our products and services by clients and prospective clients, including (i) the willingness of existing clients to maintain or increase their spending on products and services that are or remain profitable for us, and (ii) our ability to predict changes in client needs and preferences; (c) economic and other business factors that impact the industry verticals we serve, including competition and consolidation of current and prospective clients, vendors and partners in these verticals; (d) our ability to manage and timely adjust our facilities, capacity, workforce and cost structure to effectively serve our clients; (e) our ability to improve our processes and to provide new products and services in a timely and cost-effective manner though development, license, partnership or acquisition; (f) our ability to protect our facilities against security breaches and other interruptions and to protect sensitive personal information of our clients and their customers; (g) our ability to respond to increasing concern, regulation and legal action over consumer privacy issues, including changing requirements for collection, processing and use of information; (h) the impact privacy and other regulations, including restrictions on unsolicited marketing communications and other consumer protection laws; (i) fluctuations in fuel prices, paper prices, postal rates and postal delivery schedules; (j) the number of shares, if any, that we may repurchase in connection with our repurchase program; (k) unanticipated developments regarding litigation or other contingent liabilities; (l) the ability to integrate and successfully leverage newly-acquired service offerings as anticipated; (m) our ability to complete anticipated divestitures and reorganizations; and (n) other factors discussed from time to time in our filings with the Securities and Exchange Commission, including under “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2016 and in our Quarterly Report on Form 10-Q for the three months ended March 31, 2017.  The forward-looking statements in this press release and our related earnings conference call are made only as of the date hereof and we undertake no obligation to update publicly any forward-looking statement, even if new information becomes available or other events occur in the future.

Supplemental Non-GAAP Financial Measures:

In this press release and our related earnings conference call, the company may use certain non-GAAP measures of financial performance in order to provide investors with a better understanding of operating results and underlying trends to assess the company’s performance and liquidity.  The company evaluates its operating performance based on several measures, including non-GAAP financial measures.  The company believes that certain non-GAAP financial measures are useful supplemental financial measures of operating performance for investors because they facilitate investors’ ability to evaluate the operational strength of the company’s business.  Any supplemental financial measures referred to are not calculated in accordance with GAAP and they should not be considered substitutes for net income as an indicator of operating performance.

As used herein, “Harte Hanks” refers to Harte Hanks, Inc.  and/or its applicable operating subsidiaries, as the context may require.  Harte Hanks’ logo and name are trademarks of Harte Hanks.

Contact: Scott Hamilton Public & Investor Relations (303) 214 - 5563 scott.hamilton@hartehanks.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 8

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 8

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 12

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 9

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 11

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 7

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 6

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 12

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 12

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading

Top 5 Most Recently Viewed Articles

Investing $1000 in Lockheed Martin: A Decade of Growth

Updated Category News Views 91

Unlocking the Power of $1000: The Journey of Lockheed Martin Lockheed Martin has excelled in the stock market, delivering impressive returns for investors who bought shares a decade ago. With a current market capitalization of $138.10 billion, this defense powerhouse has consistently outperformed the market, achieving an annualized growth rate that surpasses expectations....

Continue Reading
Fortis Financial Performance Update: Q4 Earnings Insights

Updated Category News Views 169

Fortis Financial Performance Overview Fortis (NYSE: FTS) has recently shared its Q4 earnings results, revealing strong performance that is worth a closer look. The company's earnings announcement not only highlights its financial health but also offers insights for investors and stakeholders alike. Earnings Highlights In its latest announcement, Fortis exceeded earnings...

Continue Reading
Flowers Foods Increases Quarterly Dividend to $0.24 Per Share

Updated Category News Views 100

Flowers Foods Declares Increased Quarterly Dividend Flowers Foods, Inc. (NYSE: FLO) has recently taken significant steps in its financial directives by announcing a quarterly dividend of $0.24 per share. This marks a commendable increase of 4.3% compared to the same quarter last year. Impressively, this is the 90th consecutive quarterly dividend paid by the company....

Continue Reading
Freeport McMoRan Adjusts Copper Sales Amid Production Setbacks

Updated Category News Views 65

Freeport McMoRan to Delay Indonesian Copper Sales Freeport McMoRan, a significant player in the copper mining industry, has announced a postponement of its refined copper sales from Indonesia to the second quarter of 2025. This decision follows a fire incident at its new smelter, causing an unexpected delay in production. Production Challenges at Manyar Smelter The Manyar...

Continue Reading
Snowflake and Palantir: Revolutionizing AI in Data Management

Updated Category News Views 240

Understanding the Important Deal Between Snowflake and Palantir Snowflake Inc. (NYSE: SNOW) has recently entered a significant partnership with Palantir Technologies Inc. (NYSE: PLTR), marking an important milestone in its ambitious journey towards enhancing artificial intelligence (AI) capabilities for businesses. This collaboration aims to foster enterprise AI...

Continue Reading